Developer docs
API playgroundTry for free, no card

Search company profiles

Luscii

Full company profile

uuid0005tga

Namestring
Luscii
Legal namestring
Luscii healthtech B.V.
Websiteurl
luscii.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Luscii healthtech B.V. is a Dutch digital health company founded in 2018 in Utrecht by Prof. Daan Dohmen, Dr. Joris Janssen, Ronald Scheffer and Erik Kaufman. The company has built a remote patient monitoring (RPM) and virtual care platform — branded Luscii Vitals — that is CE-certified as a Class IIa medical device and used by 85% of Dutch hospitals, with 350+ implementations across 11 countries and more than 25 million registrations processed. Its product surface comprises a patient-facing iOS/Android app for submitting measurements and receiving care instructions, a clinical backend (Clinical Engine) that applies threshold-based and combinatorial alerts, a professional web dashboard for clinicians, and a Luscii Networks module that coordinates care across hospitals, GPs, community providers and virtual call centers. The platform integrates directly into major EMR/EHR systems via open FHIR APIs (e.g., HiX/Chipsoft, Epic) and supports a broad Bluetooth-connected device ecosystem including OMRON blood pressure monitors and scales, AliveCor Kardia 6L, MIR Spirometer, iHealth Track and CareSense N Premier.

Luscii monetizes primarily through enterprise SaaS subscriptions sold to hospitals, general practitioners, regional healthcare networks and government health programs, with quote-based pricing and no public tiers disclosed. A complementary revenue mechanics layer is the Certified Medical Developer (CMD) program, in which clinicians use Luscii Builder — a no-code drag-and-drop editor with 1,000+ building blocks — to author remote monitoring programs and monetize them through a 70% revenue-share model, with programs shared via the Luscii Library (100+ conditions). Distribution combines direct enterprise field sales with embedded partnerships (notably Graphnet Health in the UK, covering nearly nine million NHS patients), community-led growth via the CMD program, and a product-led motion through the Library and Academy training.

The company was acquired in April 2024 by OMRON Healthcare Co. Ltd. (Japan), which integrated Luscii into its 'Going for Zero' strategy. Luscii now operates as a wholly-owned subsidiary under the 'Luscii an OMRON Health Service' brand, retaining its Utrecht headquarters and serving customers in the Netherlands, UK, Germany, France, the United States and Africa, with certifications including ISO 27001:2022, ISO 13485, NEN 7510/7512/7513, UK Cyber Essentials and GDPR compliance.

Short descriptiontext

Luscii is a Dutch digital health company that provides a CE-certified Class IIa remote patient monitoring platform (Luscii Vitals) to hospitals, GPs and regional healthcare networks across 11 countries, integrating with EMR/EHR systems and now operating as a subsidiary of OMRON Healthcare.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAmsterdam, Netherlands
HQ citystring
Amsterdam
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, digital health platform, virtual care software, clinical decision support, care coordination tools
Industry5 codes
1Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
CodeHLACAFAOPrimaryYes
2Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration)
CodeHLACAPAJPrimaryNo
3EHR/EMR Integration & Interoperability Middleware (HL7/FHIR)
CodeHLALAKADPrimaryNo
4Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE)
CodeHLACABAAPrimaryNo
5Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology)
CodeHLALABADPrimaryNo
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Health Services8000
  • Services-Computer Integrated Systems Design7373
Product category
Remote Patient Monitoring
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Luscii provides a digital health platform for remote patient monitoring to healthcare organizations (hospitals, GPs, regional care networks) on a subscription basis. Healthcare institutions purchase Luscii's services to provide patients with remote monitoring. Pricing is likely institutional/enterprise-level based on scale and programs deployed.

luscii.com
2Medical Developer Program Revenue Sharing
TypeLicensing Royalties
Description

Certified Medical Developers who create programs using Luscii Builder receive 70% of revenues generated from their shared programs in the Luscii Library. Developers can credit revenue to their organization or donate to Luscii's Purpose Fund.

luscii.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others
Pricing details1 tier
1Enterprise Healthcare Organizations
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing for hospitals, healthcare systems, and regional care organizations. No public pricing tiers listed.

luscii.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Luscii Builder
Description

A drag-and-drop editor platform enabling Certified Medical Developers to create their own remote monitoring programs without coding.

luscii.com
+3 more records
Core offering1 text field

Luscii provides a CE-certified Class IIa digital health platform for remote patient monitoring, sold to hospitals, general practitioners, and regional healthcare networks. The platform combines a patient-facing mobile app, a Clinical Engine backend, a professional web dashboard, and a care coordination layer (Luscii Networks), with direct EMR/EHR integration via open FHIR APIs and Bluetooth connectivity to medical devices. Healthcare organizations can deploy pre-built programs from the Luscii Library covering 150+ conditions or build custom programs via the no-code Luscii Builder.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 85% of Dutch hospitals already use Luscii for daily care of thousands of patients
+4 more records
Product overview1 text field

Luscii is a digital health platform for remote patient monitoring, offering home-based care for hospitals, general practitioners, and regional healthcare networks. The core product is Luscii Vitals, a CE-certified Class IIa medical device platform comprising a patient mobile app, the Clinical Engine backend, a professional web dashboard, and the Luscii Networks care coordination feature. The platform integrates directly into EMR/EHR systems via open FHIR APIs and connects to over 100 medical devices (blood pressure monitors, pulse oximeters, scales, spirometers, ECG devices) via Bluetooth. Luscii Builder, accessible through the Certified Medical Developer (CMD) Program, enables healthcare professionals to create custom monitoring programs using a no-code drag-and-drop editor with 1,000 building blocks, with 70% revenue sharing for programs published in the Luscii Library. The platform covers over 150 disease conditions across 11 countries, with a library of 100+ clinically validated programs. Luscii was acquired by OMRON Healthcare in April 2024 and operates as an OMRON Healthcare Service.

Product and service8 records
1Luscii Vitals (Patient App)
CategoryRemote Patient Monitoring Platform
Description

The overarching CE-certified Class IIa medical device platform for remote patient monitoring. Combines a patient-facing mobile app (iOS/Android), the Clinical Engine backend, a professional web dashboard, and the Luscii Networks care coordination layer. Supports 150+ disease conditions with integration to 100+ medical devices via Bluetooth.

2Clinical Engine
CategoryClinical Decision Support Engine
Description

The clinical backend powering Luscii's remote patient monitoring. Provides configurable alerts, EMR integration via FHIR, and CE Class IIa certification. Processes patient-measured vital signs and supports clinical decision-making by healthcare providers.

3Luscii Builder
CategoryNo-Code Program Builder
Description

A no-code, drag-and-drop platform enabling Certified Medical Developers (CMDs) to create and customize digital home monitoring programs. Offers 1,000 building blocks for constructing measurement schedules, alerts, self-care content, and patient journey timelines without programming knowledge.

4Luscii Networks (Care Networks)
CategoryCare Coordination Platform
Description

A care coordination layer enabling seamless collaboration across general practitioners, hospitals, community care, and virtual call centers. Provides trend graphs, intelligent alerts, and communication tools across a shared patient network, supporting integrated care delivery.

5Luscii Library
CategoryClinical Program Library
Description

A library of 100+ pre-built remote monitoring programs created by clinicians for conditions including COPD, heart failure, hypertension, pregnancy complications, asthma, diabetes, and more. Programs are clinically validated and available for reuse by other healthcare organizations.

6Professional Dashboard (Web App)
CategoryHealthcare Professional Web Application
Description

A web-based dashboard for healthcare professionals to monitor patients, review measurements, manage programs, send messages, and configure alerts. Enables video calling, patient group management, and care network coordination. Partially WCAG 2.2 AA compliant.

7Certified Medical Developer (CMD) Program
CategoryCertification and Training Program
Description

A training and certification program enabling healthcare professionals to develop their own remote monitoring programs using Luscii Builder. Participants receive a digital course with videos, text, and assignments, followed by unlimited access to Luscii Builder. Developers retain 70% of revenue from programs shared in the Luscii Library.

8Luscii in a Box
CategoryHardware Kit for Remote Monitoring
Description

A hardware package providing pre-configured measurement devices or a pre-installed iPad for patients without internet access, enabling them to participate in remote monitoring. Available in certain geographic areas.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-03-06
Description

Graphnet Health partnered with Luscii to launch Graphnet Remote Monitoring, an integrated platform combining remote monitoring with population health and shared care records. This partnership embeds Luscii's remote monitoring capabilities within Graphnet's population health management platform used across almost nine million patients in England.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Family Nursing & Home Care (FNHC) in Jersey launched a two-year digital healthcare pilot using Luscii's technology, funded through Impact Jersey's Care Tech Challenge with up to £2m available. The Graphnet Remote Monitoring Pilot focuses initially on frailty before expanding to diabetes and wound care.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2024-01-01
Description

FNHC in Jersey uses Luscii's technology for a remote monitoring pilot project. FNHC is a healthcare organization implementing the technology for remote patient monitoring of patients submitting health information for review by healthcare professionals.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

UK population health and shared care record vendor that partnered with Luscii to launch Graphnet Remote Monitoring; an integration partner and ecosystem participant rather than a direct competitor.

TypeBroad incumbent
Description

Long-established UK/European telecare and remote monitoring provider for health and social care, offering a broader portfolio of assistive technology that overlaps with Luscii's chronic and frailty monitoring use cases.

TypeRegional player
Description

Norwegian remote patient monitoring and virtual care platform serving Nordic municipalities and hospitals, with a similar SaaS-plus-devices model and clinical-decision-support approach to Luscii.

TypeEmerging player
Description

Virtual care and telehealth platform that has pursued NHS and European virtual care contracts; comparable as a virtual care competitor to Luscii for NHS and primary-care budgets.

TypeDirect peer
Description

US-based RPM and connected health platform offering a kit-based and BYOD remote monitoring solution to providers and payers, directly comparable to Luscii's mobile app and device ecosystem approach.

TypeDirect peer
Description

Remote patient monitoring platform acquired by Best Buy, providing continuous monitoring and care-at-home services to health systems, with similar device connectivity and clinical dashboard features.

TypeEmerging player
Description

Connected medication adherence and remote monitoring provider; smaller in scale but addresses adjacent chronic-disease home monitoring use cases comparable to Luscii's chronic care programs.

TypeBroad incumbent
Description

Large incumbent medical technology company with a broad RPM and hospital-to-home portfolio including connected biosensors and population health tools, comparable in target customers to Luscii but vastly larger in scope.

TypeDirect peer
Description

UK-based virtual ward and remote patient monitoring provider serving NHS Trusts with clinician-led monitoring services; overlaps directly with Luscii's UK NHS go-to-market and chronic care focus.

TypeDirect peer
Description

Digital health platform providing remote patient monitoring and virtual care for hospitals and health systems across Europe and globally, with a comparable SaaS-and-devices model and similar hospital-segment GTM.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers18 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration15 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Luscii

Remote Patient Monitoringluscii.com

Luscii is a Dutch digital health company that provides a CE-certified Class IIa remote patient monitoring platform (Luscii Vitals) to hospitals, GPs and regional healthcare networks across 11 countries, integrating with EMR/EHR systems and now operating as a subsidiary of OMRON Healthcare.

What Luscii does

Luscii healthtech B.V. is a Dutch digital health company founded in 2018 in Utrecht by Prof. Daan Dohmen, Dr. Joris Janssen, Ronald Scheffer and Erik Kaufman. The company has built a remote patient monitoring (RPM) and virtual care platform — branded Luscii Vitals — that is CE-certified as a Class IIa medical device and used by 85% of Dutch hospitals, with 350+ implementations across 11 countries and more than 25 million registrations processed. Its product surface comprises a patient-facing iOS/Android app for submitting measurements and receiving care instructions, a clinical backend (Clinical Engine) that applies threshold-based and combinatorial alerts, a professional web dashboard for clinicians, and a Luscii Networks module that coordinates care across hospitals, GPs, community providers and virtual call centers. The platform integrates directly into major EMR/EHR systems via open FHIR APIs (e.g., HiX/Chipsoft, Epic) and supports a broad Bluetooth-connected device ecosystem including OMRON blood pressure monitors and scales, AliveCor Kardia 6L, MIR Spirometer, iHealth Track and CareSense N Premier.

Luscii monetizes primarily through enterprise SaaS subscriptions sold to hospitals, general practitioners, regional healthcare networks and government health programs, with quote-based pricing and no public tiers disclosed. A complementary revenue mechanics layer is the Certified Medical Developer (CMD) program, in which clinicians use Luscii Builder — a no-code drag-and-drop editor with 1,000+ building blocks — to author remote monitoring programs and monetize them through a 70% revenue-share model, with programs shared via the Luscii Library (100+ conditions). Distribution combines direct enterprise field sales with embedded partnerships (notably Graphnet Health in the UK, covering nearly nine million NHS patients), community-led growth via the CMD program, and a product-led motion through the Library and Academy training.

The company was acquired in April 2024 by OMRON Healthcare Co. Ltd. (Japan), which integrated Luscii into its 'Going for Zero' strategy. Luscii now operates as a wholly-owned subsidiary under the 'Luscii an OMRON Health Service' brand, retaining its Utrecht headquarters and serving customers in the Netherlands, UK, Germany, France, the United States and Africa, with certifications including ISO 27001:2022, ISO 13485, NEN 7510/7512/7513, UK Cyber Essentials and GDPR compliance.

Luscii firmographics

Firmographics
Name
Luscii
Legal name
Luscii healthtech B.V.
Website
https://luscii.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Luscii is a Dutch digital health company that provides a CE-certified Class IIa remote patient monitoring platform (Luscii Vitals) to hospitals, GPs and regional healthcare networks across 11 countries, integrating with EMR/EHR systems and now operating as a subsidiary of OMRON Healthcare.
Ownership category
akta.pro rank

Luscii industry classification

Industry
Product category
Remote Patient Monitoring
NAICS
Computer Systems Design and Related Services (54151), Computer Systems Design Services (541512)
SIC
Services-Health Services (8000), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)
akta.pro secondary industries
Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration) (HLACAPAJ), EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD), Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

Keywords

  • Remote patient monitoring
  • Digital health platform
  • Virtual care software
  • Clinical decision support
  • Care coordination tools

Where Luscii is headquartered

Location

Headquarters

HQ city
Amsterdam
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Luscii business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

  1. SaaS Platform Subscription: Luscii provides a digital health platform for remote patient monitoring to healthcare organizations (hospitals, GPs, regional care networks) on a subscription basis. Healthcare institutions purchase Luscii's services to provide patients with remote monitoring. Pricing is likely institutional/enterprise-level based on scale and programs deployed.
  2. Medical Developer Program Revenue Sharing: Certified Medical Developers who create programs using Luscii Builder receive 70% of revenues generated from their shared programs in the Luscii Library. Developers can credit revenue to their organization or donate to Luscii's Purpose Fund.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise Healthcare Organizations

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Luscii product offering

Product offering

Core offering

Luscii provides a CE-certified Class IIa digital health platform for remote patient monitoring, sold to hospitals, general practitioners, and regional healthcare networks. The platform combines a patient-facing mobile app, a Clinical Engine backend, a professional web dashboard, and a care coordination layer (Luscii Networks), with direct EMR/EHR integration via open FHIR APIs and Bluetooth connectivity to medical devices. Healthcare organizations can deploy pre-built programs from the Luscii Library covering 150+ conditions or build custom programs via the no-code Luscii Builder.

Product overview

Luscii is a digital health platform for remote patient monitoring, offering home-based care for hospitals, general practitioners, and regional healthcare networks. The core product is Luscii Vitals, a CE-certified Class IIa medical device platform comprising a patient mobile app, the Clinical Engine backend, a professional web dashboard, and the Luscii Networks care coordination feature. The platform integrates directly into EMR/EHR systems via open FHIR APIs and connects to over 100 medical devices (blood pressure monitors, pulse oximeters, scales, spirometers, ECG devices) via Bluetooth. Luscii Builder, accessible through the Certified Medical Developer (CMD) Program, enables healthcare professionals to create custom monitoring programs using a no-code drag-and-drop editor with 1,000 building blocks, with 70% revenue sharing for programs published in the Luscii Library. The platform covers over 150 disease conditions across 11 countries, with a library of 100+ clinically validated programs. Luscii was acquired by OMRON Healthcare in April 2024 and operates as an OMRON Healthcare Service.

Differentiator

Problem solved

Functional benefit

Brands

  • Luscii Builder: A drag-and-drop editor platform enabling Certified Medical Developers to create their own remote monitoring programs without coding.
  • Clinical Engine
  • Luscii Vitals
  • Luscii Networks

Products and services

  • Luscii Vitals (Patient App) The overarching CE-certified Class IIa medical device platform for remote patient monitoring. Combines a patient-facing mobile app (iOS/Android), the Clinical Engine backend, a professional web dashboard, and the Luscii Networks care coordination layer. Supports 150+ disease conditions with integration to 100+ medical devices via Bluetooth.
  • Clinical Engine The clinical backend powering Luscii's remote patient monitoring. Provides configurable alerts, EMR integration via FHIR, and CE Class IIa certification. Processes patient-measured vital signs and supports clinical decision-making by healthcare providers.
  • Luscii Builder A no-code, drag-and-drop platform enabling Certified Medical Developers (CMDs) to create and customize digital home monitoring programs. Offers 1,000 building blocks for constructing measurement schedules, alerts, self-care content, and patient journey timelines without programming knowledge.
  • Luscii Networks (Care Networks) A care coordination layer enabling seamless collaboration across general practitioners, hospitals, community care, and virtual call centers. Provides trend graphs, intelligent alerts, and communication tools across a shared patient network, supporting integrated care delivery.
  • Luscii Library A library of 100+ pre-built remote monitoring programs created by clinicians for conditions including COPD, heart failure, hypertension, pregnancy complications, asthma, diabetes, and more. Programs are clinically validated and available for reuse by other healthcare organizations.
  • Professional Dashboard (Web App) A web-based dashboard for healthcare professionals to monitor patients, review measurements, manage programs, send messages, and configure alerts. Enables video calling, patient group management, and care network coordination. Partially WCAG 2.2 AA compliant.
  • Certified Medical Developer (CMD) Program A training and certification program enabling healthcare professionals to develop their own remote monitoring programs using Luscii Builder. Participants receive a digital course with videos, text, and assignments, followed by unlimited access to Luscii Builder. Developers retain 70% of revenue from programs shared in the Luscii Library.
  • Luscii in a Box A hardware package providing pre-configured measurement devices or a pre-installed iPad for patients without internet access, enabling them to participate in remote monitoring. Available in certain geographic areas.

Quantifiable outcome

  • 85% of Dutch hospitals already use Luscii for daily care of thousands of patients
  • +4 more outcomes

Companies that use Luscii

Customer profile

Named customers18 records

Segments5 records

Ideal customer profiles5 records

Luscii technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration15 records

AI capability3 records

Feature5 records

Luscii partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Graphnet HealthcoreTechnology or Integration · 6 March 2025Graphnet Health partnered with Luscii to launch Graphnet Remote Monitoring, an integrated platform combining remote monitoring with population health and shared care records. This partnership embeds Luscii's remote monitoring capabilities within Graphnet's population health management platform used across almost nine million patients in England.
  • Impact Jersey / Care Tech ChallengeminorStrategic or Co-development Partner · 1 January 2024Family Nursing & Home Care (FNHC) in Jersey launched a two-year digital healthcare pilot using Luscii's technology, funded through Impact Jersey's Care Tech Challenge with up to £2m available. The Graphnet Remote Monitoring Pilot focuses initially on frailty before expanding to diabetes and wound care.
  • Family Nursing & Home Care (FNHC) JerseyminorImplementation/ SI/ Consulting Partner · 1 January 2024FNHC in Jersey uses Luscii's technology for a remote monitoring pilot project. FNHC is a healthcare organization implementing the technology for remote patient monitoring of patients submitting health information for review by healthcare professionals.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Luscii competitors and assessment

Company assessment

Others

  • Graphnet Health: UK population health and shared care record vendor that partnered with Luscii to launch Graphnet Remote Monitoring; an integration partner and ecosystem participant rather than a direct competitor.

Broad incumbents

  • Tunstall Healthcare: Long-established UK/European telecare and remote monitoring provider for health and social care, offering a broader portfolio of assistive technology that overlaps with Luscii's chronic and frailty monitoring use cases.
  • Philips Remote Patient Monitoring: Large incumbent medical technology company with a broad RPM and hospital-to-home portfolio including connected biosensors and population health tools, comparable in target customers to Luscii but vastly larger in scope.

Regional players

  • Dignio: Norwegian remote patient monitoring and virtual care platform serving Nordic municipalities and hospitals, with a similar SaaS-plus-devices model and clinical-decision-support approach to Luscii.

Emerging players

  • Babylon Health: Virtual care and telehealth platform that has pursued NHS and European virtual care contracts; comparable as a virtual care competitor to Luscii for NHS and primary-care budgets.
  • Hospify / HealthBeacon: Connected medication adherence and remote monitoring provider; smaller in scale but addresses adjacent chronic-disease home monitoring use cases comparable to Luscii's chronic care programs.

Direct peers

  • Vivify Health: US-based RPM and connected health platform offering a kit-based and BYOD remote monitoring solution to providers and payers, directly comparable to Luscii's mobile app and device ecosystem approach.
  • Current Health (Best Buy Health): Remote patient monitoring platform acquired by Best Buy, providing continuous monitoring and care-at-home services to health systems, with similar device connectivity and clinical dashboard features.
  • Doccla: UK-based virtual ward and remote patient monitoring provider serving NHS Trusts with clinician-led monitoring services; overlaps directly with Luscii's UK NHS go-to-market and chronic care focus.
  • Huma (formerly Medopad): Digital health platform providing remote patient monitoring and virtual care for hospitals and health systems across Europe and globally, with a comparable SaaS-and-devices model and similar hospital-segment GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Luscii social profiles

Digital presence

Luscii compliance and trust

Trust signal

Compliance8 records

Luscii financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Luscii leadership team

Management profile

Number of profiles

Profiles4 records

Luscii funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Luscii M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Luscii

What does Luscii do?

Luscii provides a CE-certified Class IIa digital health platform for remote patient monitoring, sold to hospitals, general practitioners, and regional healthcare networks. The platform combines a patient-facing mobile app, a Clinical Engine backend, a professional web dashboard, and a care coordination layer (Luscii Networks), with direct EMR/EHR integration via open FHIR APIs and Bluetooth connectivity to medical devices. Healthcare organizations can deploy pre-built programs from the Luscii Library covering 150+ conditions or build custom programs via the no-code Luscii Builder.

Is Luscii a public or private company?

Luscii is a private company. It is classified as corporate owned and is currently operating.

When was Luscii founded?

Luscii was founded in 2018. It employs 11 to 50 people.

Where is Luscii based?

Luscii is headquartered in Amsterdam, Netherlands, in the Europe region.

How does Luscii make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are medical Developer Program Revenue Sharing.

Who are Luscii's main competitors?

Graphnet Health is listed as an others. Broad incumbents are Tunstall Healthcare and Philips Remote Patient Monitoring. Dignio is listed as a regional player. Emerging players are Babylon Health and Hospify / HealthBeacon. Direct peers are Vivify Health, Current Health (Best Buy Health), Doccla and Huma (formerly Medopad).

Does Luscii have an API?

No public API is recorded for Luscii.

What industry is Luscii in?

Luscii's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways), with a secondary code of HLACAPAJ, Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration). Its NAICS code is 54151 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comLifestyle Diseases Apps Market Overview, Key Developments, and Insights on Major PlayersThe lifestyle diseases apps market is projected to reach $15.48 billion by 2030, growing at a 16.5% compound annual growth rate, driven by demand for personalized digital therapeutics, AI-driven health analytics, and remote patient monitoring. In April 2024, Japan-based OMRON Healthcare Co. Ltd. acquired Netherlands-based Luscii Healthtech to enhance its digital ecosystem with real-time health monitoring capabilities for chronic conditions. Additionally, Siemens Healthineers launched the Atellica DCA Analyzer in July 2024, a point-of-care device for HbA1c testing that delivers lab-quality results within 4-5 minutes.BBCDigital healthcare project in Jersey 'making a difference'Family Nursing & Home Care (FNHC) has launched a two-year digital healthcare pilot project in Jersey called the Graphnet Remote Monitoring Pilot, using Luscii's technology to allow patients to submit health information for remote monitoring by healthcare professionals. The project, which focuses initially on frailty before expanding to diabetes and wound care, has already enabled clinical staff to identify and act on patient issues flagged through the data. The scheme is funded through Impact Jersey's Care Tech Challenge, which had up to £2m available for developing technological solutions to health issues.openPR.comSegmentation, Major Trends, and Competitive Overview of the Remote Patient Monitoring System MarketThe remote patient monitoring system market is projected to reach $13.24 billion by 2030, expanding at a compound annual growth rate (CAGR) of 20.5%, driven by advancements in wearable sensors, IoT devices, telemedicine platforms, and AI-powered analytics. In April 2024, Japan's OMRON Healthcare Co. Ltd. acquired Netherlands-based digital-health company Luscii Healthtech to boost its digital health offerings and support its 'Going for Zero' initiative. Additionally, US-based BioIntelliSense, Inc. received FDA approval in October 2024 for its rechargeable BioButton Multi-Patient wearable and BioDashboard system, enabling continuous vital signs monitoring across hospital and home care settings.Digital HealthNHS population health analytics supporting early interventionPopulation health analytics delivered by Graphnet Health have been embedded across almost nine million patients in England, using the Johns Hopkins ACG System methodology to identify and stratify patients for earlier intervention. In East Kent, a 12-month proactive care programme focused on people living with frailty and complex needs saw emergency department attendances fall by approximately 69% and emergency hospital admissions reduce by around 70%. Graphnet Health has also partnered with Luscii to launch Graphnet Remote Monitoring, an integrated platform combining remote monitoring with population health and shared care records.PR NewswireOMRON Healthcare supera los 400 millones de monitores de presión arterial vendidosOMRON Healthcare Co., Ltd. announced in September 2025 that its cumulative global blood pressure monitor sales have exceeded 400 million units, marking a milestone achieved over more than 50 years since the launch of its first device in 1973. The company, headquartered in Kyoto, Japan, distributes its products in over 130 countries and regions, with a focus on expanding into emerging markets where preventive healthcare resources remain limited. OMRON Healthcare is also advancing its digital health business, including the acquisition of subsidiary Luscii and FDA-approved AI-based atrial fibrillation detection technology Intellisense AFib.PR NewswireOMRON Healthcare Exceeds 400M Blood Pressure Monitors SoldOMRON Healthcare announced that cumulative worldwide sales of its blood pressure monitors have exceeded 400 million units, marking a major milestone since launching its first device in 1973. The company, which distributes products in over 130 countries, highlighted its commitment to preventive cardiovascular care through connected devices, AI-powered atrial fibrillation detection, and digital health platforms including the recent acquisition of subsidiary Luscii. OMRON's "Going for Zero" vision aims to eradicate cerebro-cardiovascular events globally by connecting daily life with healthcare through technology.PR NewswireOMRON Healthcare Exceeds 400M Blood Pressure Monitors SoldOMRON Healthcare Co., Ltd. announced that cumulative worldwide sales of its blood pressure monitors have exceeded 400 million units, marking a significant milestone since launching its first device in 1973. The company, which distributes in over 130 countries and has expanded into digital health through acquisitions like Luscii, reaffirmed its commitment to preventive cardiovascular care with its "Going for ZERO" vision to eradicate cerebro-cardiovascular events globally. OMRON Healthcare continues to innovate with AI-powered atrial fibrillation detection and connected monitoring devices that integrate with its digital health platforms.AntsrouteImproving Home Care Logistics Using Artificial IntelligenceAI-based applications are being deployed across Europe to optimize home healthcare logistics, including route planning, caregiver assignment, and patient monitoring through connected devices. Several platforms—including AntsRoute for route optimization and Luscii for remote patient monitoring—are demonstrating measurable outcomes, with studies showing up to 65% reduction in emergency room visits and UK home care company Cera Care claiming to save the NHS approximately £1 million per day by reducing hospital admissions. While adoption is expanding—with Berg Insight projecting European teleassistance users will grow from 13 million in 2023 to 23 million by 2028—challenges around data protection, staff training, and technology accessibility remain barriers to widespread implementation.MediohRemote Patient Monitoring & Telehealth Trends 2024The article argues that traditional telehealth use among Medicaid users has fallen from 48% in 2020 to about 13% by late 2023, citing CMS data, and that Remote Patient Monitoring offers a scalable alternative. It cites Berkshire Hathaway's projection of a global RPM market exceeding $116.84 billion by 2031, and notes OMRON's acquisition of Luscii Healthtech. Implementation hurdles include data security, integration and onboarding.PR NewswireOMRON Healthcare Acquires Luscii Healthtech to Advance and Innovate Remote Patient-monitoring Adoption at ScaleOMRON Healthcare Co., Ltd. announced the acquisition of Luscii Healthtech, a digital health platform provider specializing in remote patient monitoring. This move expands OMRON's capabilities in digital health services to support its "Going for Zero" vision for preventing cardiovascular events. The acquisition leverages Luscii's market leadership in the Netherlands and presence across Europe and Africa to scale integrated care network solutions.